References
- Davis JR, Jennings RT, Beck BG (1993) Comparison of treatment strategies for space motion sickness. Acta Astronautica 29(8): 587–591
- Gilman AG (1990) Goodman and Gilman's The Pharmacological Basis of Therapeutics, 8th edn, New York: Pergamon Press
- Knox G (2014) Motion sickness: an evolutionary and genetic basis for the negative reinforcement model. Aviation, Space, and Environmental Medicine 85(1): 46–49
- McEvoy G (2005) AHFS Drug Information, Bethesda, MD: American Society of Health System Pharmacists, Inc.
- Nachum Z, Shupak A, Gordon C (2006) Transdermal scopolamine for prevention of motion sickness: clinical pharmacokinetics and therapeutic applications. Clinical Pharmacokinetics 45: 543–566
- Oman C (1982) A heuristic mathematical model for the dynamics of sensory conflict and motion sickness. Acta Otolaryngologica Supplement 392: 1–44
- Parrott A, Jones R (1985) Effects of transdermal scopolamine upon psychological test performance at sea. European Journal of Clinical Pharmacology 28: 419–423
- Wood S (2002) Human otolith-ocular reflexes during off-vertical axis rotation: effect of frequency on tilt-translation ambiguity and motion sickness. Neuroscience Letters 323: 41–44